(Q34038325)

30 July 2017

title

Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? (English)

1 reference

30 July 2017

1 reference

Rinaa S Punglia

1

1 reference

30 July 2017

Stuart J Schnitt

series ordinal

2

1 reference

30 July 2017

Jane C Weeks

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

25 September 2013

1 reference

Journal of the National Cancer Institute

30 July 2017

published in

1 reference

30 July 2017

volume

105

1 reference

30 July 2017

issue

20

1 reference

30 July 2017

page(s)

1527-1533

1 reference

30 July 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Trends in the treatment of ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

The management of ductal carcinoma in situ of the breast: a screened population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Do myoepithelial cells hold the key for breast tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Distinct epigenetic changes in the stromal cells of breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Myoepithelial cells: good fences make good neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

Effectiveness of Radiation Therapy in Older Women With Ductal Carcinoma In Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT256

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJT256

1 reference

release_seh4k5vnrra5rermnqh6g6jwyy

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/seh4k5vnrra5rermnqh6g6jwyy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference